MacroGenics Licenses Synthon’s Technology to Develop an Anti-B7-H3 ADC
Dec 12, 2016 21:30 pm UTC| Business
ROCKVILLE, Md. and NIJMEGEN, the Netherlands, Dec. 12, 2016 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based...
Universal Stainless Expands Its Commitment to the Investment Community
Dec 12, 2016 21:27 pm UTC| Business
BRIDGEVILLE, Pa., Dec. 12, 2016 -- Universal Stainless Alloy Products, Inc. (Nasdaq:USAP) announced that it has become a corporate member of BetterInvestingTM (also known as National Association of Investors...
BMC Stock Holdings, Inc. Announces Commencement of Public Offering by Selling Stockholders
Dec 12, 2016 21:24 pm UTC| Business
ATLANTA, Dec. 12, 2016 -- BMC Stock Holdings, Inc. (NASDAQ:BMCH) (“BMC”) announced today the commencement of a public offering of 1,500,000 shares of its common stock by affiliates of Davidson Kempner Capital Management...
Hancock Holding Company Announces Public Offering of Common Stock
Dec 12, 2016 21:17 pm UTC| Business
GULFPORT, Miss., Dec. 12, 2016 -- Hancock Holding Company (“Hancock”) (Nasdaq:HBHC) today announced it has commenced an underwritten registered public offering of 5 million shares of its common stock. The Company...
Ambac Appoints Claude LeBlanc as President and Chief Executive Officer
Dec 12, 2016 21:15 pm UTC| Business
NEW YORK, Dec. 12, 2016 -- Ambac Financial Group, Inc. (Nasdaq:AMBC) (“AFG”), a holding company whose subsidiaries, including Ambac Assurance Corporation (“AAC” and together with AFG, “Ambac”), provide financial...
Dec 12, 2016 21:15 pm UTC| Business
HOUSTON, TEXAS, Dec. 12, 2016 -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its fourth quarter and fiscal year 2016 results on Thursday, December 15,...
Inovalon Updates Full Year 2016 Financial Guidance
Dec 12, 2016 21:15 pm UTC| Business
Summary Full year 2016 revenue now expected to be $426 - $428 millionReduction in guidance due to inability to enter into expected collaboration agreement as a result of unforeseen circumstances impacting...